Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI United Kingdom (FTSE) (EWU) vs Teladoc Health Inc (TDOC) Price & Performance

iShares MSCI United Kingdom (FTSE)Trade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI United Kingdom (FTSE) vs Teladoc Health Inc — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.52 (market cap $3.62B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: iShares MSCI United Kingdom (FTSE) is far larger — about 3.6× Teladoc Health Inc's market cap, and iShares MSCI United Kingdom (FTSE) is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 46 Days and Teladoc Health Inc for 39 Days on average.

EWUTDOC
Market Cap
$3.62B$1.01B
Volume
923,8964,668,477
Sector
Broad Market / FactorHealth
52-Week High
$49.39$9.72
52-Week Low
$41.34$4.47
Typical Hold Time
46 Days39 Days
Enterprise Value
—$1.27B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI United Kingdom (FTSE)

EWU trades at $46.23, up 0.65% today, but technical indicators show a bearish trend with 16 sell signals versus 3 buy signals. The stock faces resistance at $47 and finds support at $45. Recent news highlights UK market volatility driven by rising gilt yields and inflation concerns, though some sectors like housebuilders have rallied on government support programs. Financial ratios remain unavailable in current data.

The outlook is cautious due to macroeconomic pressures from rising interest rates and energy costs. Investment opportunities exist in sector-specific rallies, but risks include prolonged inflation and ECB policy tightening. Stock performance hinges on UK economic stability and sectoral resilience amid global volatility.

Teladoc Health Inc

TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.

The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWU

No sentiment data available yet.

TDOC
100% Buy0% Sell
Avg holding period · 39 Days

About iShares MSCI United Kingdom (FTSE)

EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.

Read more on EWU →

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →